Sign In  |  Register  |  About Daly City  |  Contact Us

Daly City, CA
September 01, 2020 1:20pm
7-Day Forecast | Traffic
  • Search Hotels in Daly City

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

InvestorNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Names Computational Biology Pioneer as New Scientific Advisory Board Member

Predictive Oncology (NASDAQ: POAI) has announced a new member of its Scientific Advisory Board: Robert F. Murphy, PhD, a pioneer in the field of machine learning and analytics for biological data, will be joining the board and working with other experts in a variety of fields to guide the POAI’s scientific initiatives and growth strategy. An expert in developing algorithms and models designed to understand biological systems and relationships, Murphy currently serves as head of the computational biology department at Carnegie Mellon University (“CMU”). He has also served a professor of biological sciences, biomedical engineering and machine learning, all at CMU. He is a recipient of an Alexander von Humboldt Foundation Senior Research Award and is a fellow of the Institute of Electrical and Electronics Engineers and the American Institute for Medical and Biological Engineering; he also served as president of the International Society for Advancement of Cytometry. “Dr. Murphy brings a depth of knowledge that allows us to expand the boundaries of scientific research and how we can use our technology and domain expertise to generate proprietary data for our partners. His experience with ground-breaking research is vital to the evolution of our predictive models and goal to discover more effective cancer therapies,” said Predictive Oncology CEO and chairman of the board Raymond F. Vennare in the press release. “

To view the full press release, visit https://ibn.fm/TeYVy

About Predictive Oncology Inc.

Predictive Oncology, a science-driven company on the leading edge of oncology drug discovery, offers an unrivaled suite of solutions for the biopharma industry. Through the integration of scientific rigor and machine learning, the company has developed the ability to advance molecules into medicine more confidently by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the world’s largest privately held biobank of more than 150,000 tumor samples. Predictive Oncology’s solutions additionally include tumor models, biologics development, formulation design, a GMP facility, a CLIA laboratory and substantial scientific domain expertise. For more information about the company, please visit www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 DalyCity.com & California Media Partners, LLC. All rights reserved.